Your browser doesn't support javascript.
loading
Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1ß, IL-12/VEGF, and IL-10/IP-10 Axis.
Garcia, Nadja Pinto; Júnior, Alexander Leonardo S; Soares, Geyse Adriana S; Costa, Thainá Cristina C; Dos Santos, Alicia Patrine C; Costa, Allyson Guimarães; Tarragô, Andréa Monteiro; Martins, Rejane Nina; do Carmo Leão Pontes, Flávia; de Almeida, Emerson Garcia; de Paula, Erich Vinícius; Martins-Filho, Olindo Assis; Malheiro, Adriana.
Afiliación
  • Garcia NP; Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas (UFAM), 69077-000 Manaus, AM, Brazil.
  • Júnior ALS; Laboratório de Genômica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • Soares GAS; Programa de Pós-Graduação em Ciências Aplicadas a Hematologia, Universidade Estadual do Amazonas (PPCAH/UEA), 69065-001 Manaus, AM, Brazil.
  • Costa TCC; Programa de Apoio a Iniciação Científica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • Dos Santos APC; Programa de Pós-Graduação em Ciências Aplicadas a Hematologia, Universidade Estadual do Amazonas (PPCAH/UEA), 69065-001 Manaus, AM, Brazil.
  • Costa AG; Programa de Apoio a Iniciação Científica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • Tarragô AM; Programa de Pós-Graduação em Imunologia Básica e Aplicada, Universidade Federal do Amazonas (UFAM), 69077-000 Manaus, AM, Brazil.
  • Martins RN; Laboratório de Genômica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • do Carmo Leão Pontes F; Programa de Pós-Graduação em Ciências Aplicadas a Hematologia, Universidade Estadual do Amazonas (PPCAH/UEA), 69065-001 Manaus, AM, Brazil.
  • de Almeida EG; Laboratório de Genômica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • de Paula EV; Laboratório de Genômica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • Martins-Filho OA; Laboratório de Genômica, Fundação Hospitalar de Hematologia e Hemoterapia do Amazonas (HEMOAM), 69050-001 Manaus, AM, Brazil.
  • Malheiro A; Programa de Pós-Graduação em Ciências Aplicadas a Hematologia, Universidade Estadual do Amazonas (PPCAH/UEA), 69065-001 Manaus, AM, Brazil.
J Immunol Res ; 2020: 4585704, 2020.
Article en En | MEDLINE | ID: mdl-32411797
ABSTRACT

BACKGROUND:

Sickle cell anemia (SCA) is associated with a chronic proinflammatory state characterized by elevated leukocyte count, mortality from severe recurrent infections, and subsequent vasoocclusive complications with leukocyte adhesion to the endothelium and increased plasma levels of inflammatory cytokines. The immune system has a close connection with morbidity in SCA, but further studies are needed to uncover the involvement of innate and adaptive immunities in modulating the SCA physiopathology. We performed measurements of the frequency of innate and adaptive immunity cells, cytokines, chemokines, and growth factors and immunophenotyping of Toll-like receptor and adhesion molecule expression in the blood of SCA patients and healthy donors to evaluate the different profiles of these biomarkers, the relationship among them, and their correlation to laboratory records and death risk. Material and Methods. Immunophenotyping of cells, Toll-like receptors, and adhesion molecules were performed from peripheral blood samples of SCA patients and healthy donors by flow cytometry and cytokine/chemokine/growth factor measurement by the Luminex technique performed from the serum of the same subjects.

RESULTS:

Cells of adaptive immunity such as IL-12, IL-17, and IL-10 cytokines; IL-8, IP-10, MIP-1α, MIP-1ß, and RANTES chemokines; and VEGF, FGF-basic, and GM-CSF growth factors were higher in SCA patients than healthy donors regardless of any laboratorial and clinical condition. However, high death risk appears to have relevant biomarkers.

CONCLUSION:

In the SCA pathophysiology at steady state, there is a broad immunological biomarker crosstalk highlighted by TCD4+CD69+ lymphocytes, IL-12 and IL-17 inflammatory and IL-10 regulatory cytokines, MIP-1α, MIP-1ß, and IP-10 chemokines, and VEGF growth factor. High expression of TLR2 in monocytes and VLA-4 in TCD8+ lymphocytes and high levels of MIP-1ß and RANTES appear to be relevant in high death risk conditions. The high reticulocytosis and high death risk conditions present common correlations, and there seems to be a balance by the Th2 profile.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reticulocitos / Citocinas / Células Th2 / Inmunidad Adaptativa / Anemia de Células Falciformes Límite: Adult / Female / Humans / Male Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: EG / EGIPTO / EGITO / EGYPT

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Reticulocitos / Citocinas / Células Th2 / Inmunidad Adaptativa / Anemia de Células Falciformes Límite: Adult / Female / Humans / Male Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: Brasil Pais de publicación: EG / EGIPTO / EGITO / EGYPT